A new version of targeted minicircle producer system for EBV-positive human nasopharyngeal carcinoma

E-ISSN： 1791-2431|32|6|2564-2570

ISSN： 1021-335X

Source： Oncology Reports, Vol.32, Iss.6, 2014-01, pp. : 2564-2570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells

International Journal of Oncology, Vol. 43, Iss. 5, 2013-01 ,pp. : 1541-1548

Spandidos Publications

Access to resources Recommend Favorite

Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma

By Allen Chan K.C. Dennis Lo Y.M.

Seminars in Cancer Biology, Vol. 12, Iss. 6, 2002-12 ,pp. : 489-496

Academic Press

Access to resources Recommend Favorite

Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy

By Lee S.P.

Seminars in Cancer Biology, Vol. 12, Iss. 6, 2002-12 ,pp. : 463-471

Academic Press

Access to resources Recommend Favorite

Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2585-2601

Spandidos Publications

Access to resources Recommend Favorite

P‐glycoprotein is expressed and causes resistance to chemotherapy in EBV‐positive T‐cell lymphoproliferative diseases

Cancer Medicine, Vol. 2045-7634, Iss. 10, 2015-10 ,pp. : 1494-1504

John Wiley & Sons Inc

Access to resources Recommend Favorite